ANRS, Emerging Infectious Diseases: Communicable Diseases trials

The registry lists 16 Communicable Diseases studies with ANRS, Emerging Infectious Diseases as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 5Phase 3 3No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)RecruitingNCT06893757
• Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP UsersNot yet recruitingNCT05922735
• Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART ControlRecruitingNCT05300035Phase 2
• Primary Infection CohortRecruitingNCT03148964
• Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 InfectionStatus unknownNCT04920838Phase 2/3
• Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo.Status unknownNCT04910438
• A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)CompletedNCT04120415Phase 2
• HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)Status unknownNCT04044586
• Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected PatientsStatus unknownNCT03941210
• Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected WomenStatus unknownNCT03789513Not applicable
• Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV InfectionStatus unknownNCT03622177
• An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic InfectionTerminatedNCT02972450Phase 1/2
• Early Identification and Treatment of Early HIV Infection in Côte d'IvoireCompletedNCT01917175
• On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With MenCompletedNCT01473472Phase 3
• Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/RibavirinCompletedNCT01335529Phase 2
• Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)CompletedNCT01033760Phase 3